Phase 3 Data for Incyte's Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet

[
Phase 3 Data for Incyte's Retifanlimab (Zynyz ®) in Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC) Published in The Lancet
[og_img]
https://www.investing.com/news/press-releases/phase-3-data-for-incytes-retifanlimab-zynyz–in-patients-with-squamous-cell-carcinoma-of-the-anal-canal-scac-published-in-the-lancet-93CH-4094215


Investing.com